Papers

10

Total Citations

77

H-Index

5

About

Emanuele Serafin is a leading urological surgeon and researcher whose work focuses on refining risk stratification and surgical outcomes in prostate cancer, particularly for patients undergoing robot-assisted radical prostatectomy (RARP). His major contributions center on understanding how patient-specific factors—such as advanced age, preoperative physical status (ASA score), and surgeon volume—influence prognosis and postoperative complications. Serafin’s research has demonstrated that advanced age independently predicts disease progression in high-risk prostate cancer, while the ASA physical status system reliably forecasts major Clavien-Dindo complications at both discharge and 90 days post-surgery. He has also validated the 2012 Briganti nomogram as a powerful tool for predicting not only lymph node involvement but also disease progression across intermediate- and high-risk patient groups. With over 75 citations across his top-cited works, Serafin’s studies—published in high-impact urology journals—provide actionable insights for tailoring surgical strategies and improving patient counseling. His work on surgeon volume and operating time further underscores his commitment to optimizing care delivery in robotic surgery.

Research Focus

Key Achievements

5
H-Index
10
Papers
77
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Advanced age portends poorer prognosis after radical prostatectomy: a single center experience
30 citations · 2022
📈 Most Prolific Year: 2024 (6 Papers)
🤝 Key Collaborators: 53
🏛 Institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago